ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,06965
-0,04%
Bitcoin
63.112,24
-0,98%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Ironwood Pharmaceuticals Inc (IRWD)

  7. Ironwood Pharmaceuticals Inc (IRWD) News

IRWD Ironwood Pharmaceuticals Inc

7,85
-0,23 (-2,85%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Ironwood Pharmaceuticals Inc IRWD NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-0,23 -2,85% 7,85 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
8,09 7,77 8,17 7,82 8,08
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.4.202422:01BWIronwood Pharmaceuticals to Host First Quarter 2024 Investor..
28.3.202412:30BWIronwood Pharmaceuticals Announces Positive Results from its..
08.3.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202412:00BWIronwood Pharmaceuticals Announces Positive Topline Results..
23.2.202413:30BWIronwood Pharmaceuticals to Present Four Abstracts at the..
15.2.202413:04EDGAR2Form 8-K - Current report
15.2.202413:00BWIronwood Pharmaceuticals Reports Fourth Quarter and Full..
15.2.202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202402:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.2.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.2.202422:13EDGAR2Form 144 - Report of proposed sale of securities
09.2.202422:11EDGAR2Form 144 - Report of proposed sale of securities
09.2.202422:09EDGAR2Form 144 - Report of proposed sale of securities
09.2.202422:05EDGAR2Form 144 - Report of proposed sale of securities
01.2.202422:01BWIronwood Pharmaceuticals to Host Fourth Quarter and Full..
19.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.1.202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.1.202401:00BWIronwood Announces Publication in The Lancet..
08.1.202412:05EDGAR2Form 8-K - Current report
08.1.202412:00BWIronwood Pharmaceuticals Maintains FY 2023 Financial..
03.1.202422:01BWIronwood Pharmaceuticals to Present at the 42nd Annual J.P...
19.12.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202322:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.12.202322:26EDGAR2Form 144 - Report of proposed sale of securities
12.12.202322:01BWIronwood Announces the Completion of Squeeze-Out Merger With..
21.11.202322:01BWIronwood Pharmaceuticals to Participate in the Piper Sandler..
20.11.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202322:05EDGAR2Form 144 - Report of proposed sale of securities
09.11.202322:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
09.11.202322:07EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09.11.202313:07EDGAR2Form 8-K - Current report
09.11.202313:00BWIronwood Pharmaceuticals Reports Third Quarter 2023 Results
26.10.202322:01BWIronwood Pharmaceuticals to Host Third Quarter 2023 Investor..
23.10.202313:30BWIronwood Releases New IBS-C and CIC Data at the American..
16.10.202312:00BWIronwood Pharmaceuticals Presents Positive Final Data from..
05.10.202313:30BWIronwood to Present New Data at NASPGHAN Annual Meeting..
19.9.202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.9.202323:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.9.202322:30EDGAR2Form 8-K/A - Current report: [Amend]
31.8.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.8.202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.8.202322:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NASDAQ
IRWD
Ironwood Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten